<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03384628</url>
  </required_header>
  <id_info>
    <org_study_id>TRTN-501</org_study_id>
    <nct_id>NCT03384628</nct_id>
  </id_info>
  <brief_title>An Evaluation Of The Fitting Success Rate Of Senofilcon A Soft Contact Lenses In Three Designs.</brief_title>
  <official_title>An Evaluation Of The Fitting Success Rate Of Senofilcon A Soft Contact Lenses In Three Designs.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Graeme Young</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Visioncare Research Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Visioncare Research Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare the on-eye fitting characteristics of three types of contact lenses.
      Each lens pair will be worn for 30 to 45 minutes before assessment and the results will be
      compared to mathematically calculated fitting characteristics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be an approx. 40-60 subject, one-day, double-masked, randomised, repeated measures
      study. Each subject will wear the three lens types bilaterally in random succession, a total
      of six lenses will therefore be worn by each subject (3 per eye).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 26, 2018</start_date>
  <completion_date type="Actual">May 24, 2018</completion_date>
  <primary_completion_date type="Actual">May 24, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Each subject will wear the three contact lens types bilaterally in random succession</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Subjects will be masked to lens type and lens codes. A sealed decoding envelope will be provided to the investigator. In the event of an emergency the investigator will break the masking and the medical monitor will be notified.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Lens fit (position on the eye) in mm</measure>
    <time_frame>25 minutes</time_frame>
    <description>Horizontal Lens Centration (mm), Vertical Lens Centration (mm), Post-blink movement in primary gaze (mm), Version lag (mm), Horizontal corneal overlap (mm), Diameter acceptance (mm),</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens edge tightness fit grade 0-4</measure>
    <time_frame>5 minutes</time_frame>
    <description>Edge tightness (grade 0-4)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens tightness fit graded as %</measure>
    <time_frame>5 minutes</time_frame>
    <description>Tightness (push-up %),</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens overall fit grade 0-5</measure>
    <time_frame>5 minutes</time_frame>
    <description>Overall fit acceptability (Grade 0-5),</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>First Pair Senofilcon A contact lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The first pair of Senofilcon A contact lenses is applied (according to the fitting schedule), allowed to settle before assessment of the first pair Senofilcon A contact lens and subsequent removal.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Second pair Senofilcon A contact lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The second pair of contact lenses is applied (according to the fitting schedule), allowed to settle before assessment of the second pair Senofilcon A contact lens and subsequent removal.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Third pair Senofilcon A contact lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The third pair of Senofilcon A contact lens is applied (according to the fitting schedule), allowed to settle before assessment of the third pair Senofilcon A contact lens and subsequent removal.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>First pair Senofilcon A contact lens</intervention_name>
    <description>Fit assessment of the first pair contact lenses.</description>
    <arm_group_label>First Pair Senofilcon A contact lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Second pair Senofilcon A contact lens</intervention_name>
    <description>Fit assessment of the second pair of contact lenses.</description>
    <arm_group_label>Second pair Senofilcon A contact lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Third pair Senofilcon A contact lens</intervention_name>
    <description>Fit assessment of the third pair of contact lenses.</description>
    <arm_group_label>Third pair Senofilcon A contact lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-70 years.

          -  Able to read, comprehend and sign an informed consent.

          -  Willing to comply with the wear and study assessment schedule.

          -  Spherical distance prescription between -0.50 and -6.00 (inc.).

          -  Astigmatism, if present,≤1.50DC in both eyes.

          -  Have normal eyes with no evidence of any ocular abnormality or disease. For the
             purposes of this study a normal eye is defined as one having:

        A clear central cornea. No anterior segment disorders. No clinically significant slit lamp
        findings (i.e. corneal oedema, significant staining, central scarring, infiltrates, active
        neovascularisation). No other active ocular disease (including pterygia).

        Exclusion Criteria:

          -  Previous anterior ocular surgery

          -  Any active corneal infection, injury or inflammation

             . •Large pinguecula likely to affect soft lens fit

          -  Systemic or ocular disease or medication which might interfere with CL wear

          -  Pregnancy or breastfeeding

          -  Participation in any concurrent trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Graeme Young, PhD MPhil</last_name>
    <role>Study Director</role>
    <affiliation>Managing director</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Visioncare research</name>
      <address>
        <city>Farnham</city>
        <state>Surrey</state>
        <zip>GU9 7EN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aston University Optometry Clinic</name>
      <address>
        <city>Birmingham</city>
        <state>West Midlands</state>
        <zip>B4 7ET</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>December 8, 2017</study_first_submitted>
  <study_first_submitted_qc>December 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 27, 2017</study_first_posted>
  <last_update_submitted>June 6, 2018</last_update_submitted>
  <last_update_submitted_qc>June 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Visioncare Research Ltd.</investigator_affiliation>
    <investigator_full_name>Graeme Young</investigator_full_name>
    <investigator_title>Graeme Young PhD MPhil FCOptom DCLP</investigator_title>
  </responsible_party>
  <keyword>Contact lens</keyword>
  <keyword>The Young Theory</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Seizures</mesh_term>
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>August 25, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/28/NCT03384628/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 6, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/28/NCT03384628/ICF_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 18, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/28/NCT03384628/SAP_002.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

